Recombinant Escherichia fergusonii p-hydroxybenzoic acid efflux pump subunit AaeA (AaeA) is a protein component of an efflux pump found in Escherichia fergusonii that confers resistance to certain aromatic compounds . Efflux pumps are protein complexes that actively transport substances, including antibiotics and toxic compounds, out of the cell, thereby reducing their intracellular concentration . AaeA, along with AaeB, contributes to the efflux of aromatic carboxylic acids, playing a role in the organism's defense against these compounds .
The AaeAB efflux pump was initially identified in Escherichia coli through the upregulation of certain genes, including yhcP, in response to treatment with p-hydroxybenzoic acid (pHBA) . Subsequent research revealed that yhcP encodes a protein belonging to the putative efflux protein family . Further investigation of adjacent genes yhcQ and yhcR, along with the upstream gene yhcS, elucidated their roles in regulating the expression of yhcRQP . It was then proposed to rename yhcS, yhcR, yhcQ, and yhcP to aaeR, aaeX, aaeA, and aaeB, respectively, to reflect their function in aromatic carboxylic acid efflux .
The aaeA gene encodes the AaeA protein, which functions as a subunit of the AaeAB efflux pump . The aaeA gene is also known under the synonyms aas, EFER_2770, and Bifunctional protein Aas . The protein is 310 amino acids long .
Key characteristics of the aaeA gene and AaeA protein:
AaeA is a component of the AaeAB efflux pump, which actively transports aromatic carboxylic acids out of the bacterial cell . This efflux mechanism helps the bacterium to tolerate and resist the toxic effects of these compounds . The AaeAB efflux system is highly regulated, suggesting that it plays a role as a "metabolic relief valve" to alleviate toxic effects of imbalanced metabolism .
While AaeA primarily functions in the efflux of aromatic carboxylic acids, efflux pumps, in general, are significant contributors to antibiotic resistance in bacteria . By expelling antibiotics from the cell, bacteria can reduce the intracellular concentration of these drugs, rendering them ineffective .
Recombinant AaeA is produced in E. coli using recombinant DNA technology . The recombinant protein is expressed with an N-terminal His tag for purification purposes . Recombinant AaeA can be used in various applications, including ELISA .
Recombinant AaeA and its corresponding gene have several applications in scientific research:
Protein characterization: Studying the biochemical properties and structure of the AaeA protein to understand its function in the efflux pump complex .
Efflux pump studies: Investigating the substrate specificity, regulation, and mechanism of action of the AaeAB efflux pump .
Antimicrobial resistance research: Elucidating the role of efflux pumps, including AaeAB, in bacterial resistance to antibiotics and other antimicrobial agents .
Drug discovery: Identifying potential inhibitors of the AaeAB efflux pump to enhance the efficacy of antibiotics and other drugs .
Recombinant AaeA is typically produced in E. coli and purified using affinity chromatography based on the His tag . The purified protein is then used for downstream applications, such as structural studies, biochemical assays, and drug screening .
KEGG: efe:EFER_3219
Escherichia fergusonii is a Gram-negative, rod-shaped, facultatively anaerobic bacterium that is oxidase negative, catalase positive, and typically motile due to peritrichous flagella. It has emerged as a pathogen of increasing concern with zoonotic significance, causing conditions ranging from wound infections to hemolytic uremic syndrome (HUS) .
The bacterium is taxonomically classified within the Enterobacteriaceae family and shares the lineage: Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia . Research significance stems from its increasing recognition as both a pathogen and a reservoir of antimicrobial resistance genes. The reference strain, E. fergusonii ATCC 35469, was originally isolated from human feces and has a fully sequenced genome consisting of a 4,588,711 bp circular chromosome and a 55,150 bp plasmid (pEFER) .
Studies indicate that E. fergusonii strains from avian sources carry significantly higher numbers of antimicrobial resistance genes and mobile genetic elements compared to strains from other sources, making them potentially important vectors for the dissemination of antimicrobial resistance .
The p-hydroxybenzoic acid efflux pump subunit AaeA works in conjunction with AaeB to form a functional efflux pump system in E. fergusonii. This pump system operates as a metabolic relief valve, facilitating the elimination of specific compounds when they accumulate to high concentrations within the bacterial cell .
The primary function appears to be the extrusion of potentially harmful aromatic compounds, particularly p-hydroxybenzoic acid derivatives, which may result from bacterial metabolism or environmental exposure. This efflux system likely contributes to bacterial homeostasis by preventing the toxic accumulation of these compounds, thereby enhancing bacterial survival under specific stress conditions.
While direct experimental evidence specifically for E. fergusonii AaeA is limited in the available literature, its function can be inferred from homologous systems in related bacteria, where such efflux pumps play crucial roles in detoxification mechanisms and potentially contribute to intrinsic resistance against certain antimicrobial compounds.
The AaeA-AaeB system represents one of several classes of efflux pumps found in gram-negative bacteria. These systems typically consist of multiple protein components that span the cell envelope (inner membrane, periplasm, and outer membrane) to facilitate the export of compounds directly to the external environment.
Within the context of E. fergusonii and related Enterobacteriaceae, efflux pumps like AaeA-AaeB operate alongside other resistance mechanisms such as the AcrAB-TolC system, which has been reported in E. fergusonii genomes . While AcrAB-TolC is known to efflux a broad range of antibiotics, the AaeA-AaeB system appears more specialized for aromatic compounds.
This specialization suggests a primary role in metabolic homeostasis rather than acquired antibiotic resistance, though the capacity to extrude toxic compounds may confer some level of intrinsic resistance to certain antimicrobials. Understanding the substrate specificity and regulation of the AaeA-AaeB system could provide insights into both bacterial physiology and potential resistance mechanisms.
While the AaeA-AaeB efflux system primarily functions to extrude aromatic compounds, its activity may contribute to intrinsic resistance against certain antimicrobials, particularly those with aromatic structures. Efflux pumps have been widely recognized as contributors to antimicrobial resistance in various bacterial species.
E. fergusonii has been documented to harbor multiple antimicrobial resistance determinants, including extended-spectrum beta-lactamases (ESBLs), carbapenemases, and mobilized colistin resistance (mcr) genes . Studies have shown that avian strains of E. fergusonii carry significantly higher numbers of antimicrobial resistance genes (p < 0.05) compared to strains from bovine and ovine origins .
The relationship between AaeA-AaeB and these resistance determinants warrants investigation. Research questions might explore:
Does overexpression of AaeA-AaeB confer resistance to specific antimicrobials?
Is AaeA expression co-regulated with other resistance mechanisms under antimicrobial stress?
Can AaeA-AaeB efflux clinically relevant antibiotics, and if so, which structural classes?
Understanding these aspects could help elucidate the potential contribution of AaeA to the multidrug resistance phenotype observed in many E. fergusonii isolates.
E. fergusonii has been shown to possess numerous mobile genetic elements, including plasmids, transposons, and integrons, which facilitate horizontal gene transfer of antimicrobial resistance determinants . Analyzing the genomic context of the aaeA gene could provide insights into its evolutionary history and potential for mobilization.
The complete genome sequence of E. fergusonii ATCC 35469 includes a chromosome of 4,588,711 bp and a plasmid (pEFER) of 55,150 bp . Determining whether aaeA is chromosomally encoded or plasmid-borne is crucial for understanding its stability within the genome and potential for horizontal transfer.
Comparative genomic analyses have revealed that E. fergusonii isolates of avian origin demonstrate greater genomic diversity compared to those from other sources . This diversity, coupled with the higher prevalence of mobile genetic elements in avian strains, suggests that these isolates may be more prone to gene acquisition and loss, potentially including genes encoding efflux pump components.
Research examining the genomic neighborhood of aaeA might reveal associations with insertion sequences, transposons, or other genetic mobility elements that could facilitate its transfer between bacterial strains or species.
Phylogenetic analysis of AaeA proteins across bacterial species could provide valuable insights into the evolutionary history and functional diversification of this efflux pump component. E. fergusonii has been shown to cluster phylogenetically based on isolation source and geographical location .
Research questions in this area might include:
How conserved is AaeA among E. fergusonii strains from different sources (avian, bovine, human)?
What is the degree of sequence similarity between E. fergusonii AaeA and homologs in related species like E. coli?
Are there specific domains or motifs that are highly conserved, suggesting functional importance?
Do phylogenetic patterns suggest instances of horizontal gene transfer versus vertical inheritance?
A comparative analysis could be structured as follows:
| Species | AaeA Length | Sequence Identity to E. fergusonii AaeA | Source Isolation |
|---|---|---|---|
| E. fergusonii ATCC 35469 | 310 aa | 100% | Human fecal sample |
| E. fergusonii (avian isolates) | Variable | Variable | Poultry samples |
| E. coli | Variable | Variable | Various |
| Other Enterobacteriaceae | Variable | Variable | Various |
Such analysis could reveal evolutionary patterns that might correlate with host adaptation or pathogenicity.
E. fergusonii possesses multiple efflux systems, including the AcrAB-TolC system that is known to transport various antibiotics . Understanding the substrate specificity of AaeA-AaeB compared to these other systems would provide insights into their complementary or redundant functions.
While AaeA-AaeB appears specialized for p-hydroxybenzoic acid and related aromatic compounds, comprehensive substrate profiling using recombinant expression systems could reveal unexpected specificities. Research approaches might include:
Heterologous expression of AaeA-AaeB in a susceptible host lacking endogenous efflux pumps
Systematic testing of growth inhibition with various compounds in the presence versus absence of AaeA-AaeB
Direct transport assays using radiolabeled or fluorescent substrates
Structural modeling and docking studies to predict substrate binding
The results could be organized in a substrate specificity profile:
| Compound Class | AaeA-AaeB Activity | AcrAB-TolC Activity | Other Efflux Systems |
|---|---|---|---|
| p-Hydroxybenzoic acids | High | Variable | Variable |
| Beta-lactams | Unknown | Variable | Variable |
| Quinolones | Unknown | Variable | Variable |
| Tetracyclines | Unknown | Variable | Variable |
| Other aromatic compounds | Unknown | Variable | Variable |
Such comparative analysis would contribute to understanding the collective role of efflux systems in E. fergusonii physiology and antimicrobial resistance.
Expression of recombinant E. fergusonii AaeA protein requires careful optimization due to its nature as a membrane-associated protein. Based on available information, successful expression has been achieved in E. coli expression systems with the addition of an N-terminal His-tag for purification purposes .
A methodological approach for optimizing expression might include:
Vector selection: pET-based expression vectors under the control of the T7 promoter are commonly used for membrane proteins
Host strain selection: E. coli strains such as BL21(DE3), C41(DE3), or C43(DE3) (the latter two specifically designed for membrane protein expression)
Induction conditions:
IPTG concentration: 0.1-1.0 mM
Induction temperature: 16-30°C (lower temperatures often improve membrane protein folding)
Induction duration: 4-16 hours
Media optimization:
Rich media (LB, TB, 2YT) for high biomass production
Defined media for controlled expression and isotopic labeling if structural studies are planned
A typical expression protocol might involve:
Transform expression plasmid into the selected E. coli strain
Grow cultures to mid-log phase (OD600 of 0.6-0.8)
Reduce temperature to 20°C
Induce with 0.5 mM IPTG
Continue expression for 16 hours
Harvest cells by centrifugation
Proceed with membrane preparation and protein purification
This approach balances protein yield with proper folding, which is critical for functional studies.
Purification of membrane proteins like AaeA presents specific challenges due to their hydrophobic nature. A systematic purification strategy would typically include:
Membrane extraction:
Cell lysis using mechanical methods (sonication, French press, homogenization)
Differential centrifugation to isolate membrane fractions
Solubilization with appropriate detergents (e.g., DDM, LDAO, OG)
Affinity chromatography:
Size exclusion chromatography:
Further purification and buffer exchange
Assessment of oligomeric state
Detergent considerations:
Initial solubilization may require stronger detergents
Purification and storage often benefit from milder detergents
Consider detergent screening to identify optimal conditions
A sample purification protocol might include:
| Step | Buffer Composition | Conditions |
|---|---|---|
| Membrane extraction | 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol | 4°C |
| Solubilization | Extraction buffer + 1% DDM | 4°C, 1-2 hours |
| IMAC binding | Extraction buffer + 0.05% DDM | 4°C |
| IMAC washing | Binding buffer + 20-50 mM imidazole | 4°C |
| IMAC elution | Binding buffer + 250-500 mM imidazole | 4°C |
| Size exclusion | 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.03% DDM | 4°C |
Protein quality should be assessed at each step using SDS-PAGE, Western blotting, and potentially mass spectrometry to confirm identity.
Characterizing the functional activity of AaeA requires assays that can measure its contribution to efflux activity, ideally in conjunction with its partner protein AaeB. Several complementary approaches can be employed:
Whole-cell-based assays:
Susceptibility testing: MIC determination in the presence/absence of AaeA expression
Efflux inhibitor studies: Testing whether known efflux inhibitors affect AaeA-mediated resistance
Fluorescent substrate accumulation: Using fluorescent dyes that are potential substrates
Membrane vesicle-based assays:
Inside-out vesicles can be prepared from cells expressing AaeA-AaeB
Transport activity measured using substrate accumulation or efflux
Reconstituted systems:
Purified AaeA and AaeB can be reconstituted into proteoliposomes
Direct measurement of transport activity across the membrane
Binding assays:
Isothermal titration calorimetry (ITC) to measure substrate binding
Surface plasmon resonance (SPR) for binding kinetics
Fluorescence-based binding assays
A comprehensive characterization would include determining:
| Parameter | Method | Expected Outcome |
|---|---|---|
| Substrate specificity | Transport assays with various compounds | Profile of transported substrates |
| Kinetic parameters | Concentration-dependent transport | Km and Vmax values |
| Energy dependence | Transport in the presence of metabolic inhibitors | ATP or PMF requirement |
| Inhibitor sensitivity | Transport in the presence of efflux inhibitors | Inhibition profile |
| Partner protein dependence | Comparison of AaeA alone vs. AaeA+AaeB | Functional interaction confirmation |
These approaches would provide a comprehensive understanding of AaeA's functional properties and its role in E. fergusonii physiology.
Understanding the regulation of aaeA expression is crucial for elucidating its physiological role and potential contribution to antimicrobial resistance. A systematic approach might include:
Promoter analysis:
Computational identification of promoter elements and potential transcription factor binding sites
Reporter gene assays using the aaeA promoter fused to reporter genes (e.g., lacZ, gfp)
Transcriptional studies:
qRT-PCR to measure aaeA mRNA levels under various conditions
RNA-seq to identify co-regulated genes in the AaeA regulon
Primer extension or 5' RACE to map transcription start sites
Regulatory protein identification:
DNA-protein interaction assays (EMSA, DNase footprinting)
Chromatin immunoprecipitation (ChIP) if antibodies are available
One-hybrid or bacterial two-hybrid screens to identify regulatory proteins
Environmental and stress response analysis:
Gene expression under various growth conditions (pH, temperature, nutrient limitation)
Response to potential substrates or inducers
Antibiotic exposure effects on expression
Conditions to test might include:
| Condition | Rationale | Expected Outcome |
|---|---|---|
| Aromatic compound exposure | Potential inducers as substrates | Increased expression |
| Sub-inhibitory antibiotic concentrations | Stress response | Potential modulation |
| Growth phase variation | Metabolic state changes | Expression pattern changes |
| Oxygen limitation | Metabolic shifts | Expression changes |
| pH stress | Environmental adaptation | Potential regulation |
Results from these approaches would provide insights into when and why E. fergusonii expresses the AaeA-AaeB efflux system, potentially revealing its physiological importance and role in adaptation to different environments.